Ex-PRESS implantation with phacoemulsification in POAG versus CPACG

AIM: To compare the long-term outcomes of the Ex-PRESS miniature glaucoma device implanted under a scleral flap in combination of phacoemulsification with intraocular lens implantation in primary open angle glaucoma (POAG) and chronic primary angle-closure glaucoma (CPACG).METHODS: Retrospective, co...

Full description

Saved in:
Bibliographic Details
Published inInternational journal of ophthalmology Vol. 10; no. 1; pp. 51 - 55
Main Authors Lan, Jie, Sun, Da-Peng, Wu, Jie, Wang, Ya-Ni, Xie, Li-Xin
Format Journal Article
LanguageEnglish
Published China International Journal of Ophthalmology Press 18.01.2017
Subjects
Online AccessGet full text
ISSN2222-3959
2227-4898
DOI10.18240/ijo.2017.01.08

Cover

Abstract AIM: To compare the long-term outcomes of the Ex-PRESS miniature glaucoma device implanted under a scleral flap in combination of phacoemulsification with intraocular lens implantation in primary open angle glaucoma (POAG) and chronic primary angle-closure glaucoma (CPACG).METHODS: Retrospective, comparative study. A total of 60 eyes (60 patients) receiving the Ex-PRESS miniature glaucoma device implantation combined with phacoemulsification were reviewed. Thirty eyes (30 patients) had the combined procedures for POAG, and the other 30 eyes (30 patients) for CPACG. RESULTS: The follow-up was 39.37±7.09mo (range 3 to 49mo) in patients with POAG and 37.10±9.26mo (range 9 to 49mo) in patients with CPACG (P=0.29). The mean change in best corrected visual acuity was 0.41 logMAR for POAG and 0.38 logMAR for CPACG at the last follow-up (P=0.22). The postoperative intraocular pressure (IOP) of the POAG group was significantly lower than the CPACG group at 1, 3, 12, and 18mo after surgery (P=0.02, 0.00, 0.04, 0.01) with similar glaucoma medications after surgery (P〉0.16). At 3y after surgery, the cumulative complete and qualified success rates were 63.3% (POAG) and 53.3% (CPACG), 83.3% (POAG) and 73.3% (CPACG) (P=0.41, 0.49), respectively. The POAG group had more hypotony than the CPACG group (P=0.04).CONCLUSION: The long-term outcomes show the Ex-PRESS implantation combined with phacoemulcification can effectively lower the IOP in both the POAG and CPACG groups. The POAG group seems to have lower postoperative IOP and a higher risk of hypotony.
AbstractList AIMTo compare the long-term outcomes of the Ex-PRESS miniature glaucoma device implanted under a scleral flap in combination of phacoemulsification with intraocular lens implantation in primary open angle glaucoma (POAG) and chronic primary angle-closure glaucoma (CPACG).METHODSRetrospective, comparative study. A total of 60 eyes (60 patients) receiving the Ex-PRESS miniature glaucoma device implantation combined with phacoemulsification were reviewed. Thirty eyes (30 patients) had the combined procedures for POAG, and the other 30 eyes (30 patients) for CPACG.RESULTSThe follow-up was 39.37±7.09mo (range 3 to 49mo) in patients with POAG and 37.10±9.26mo (range 9 to 49mo) in patients with CPACG (P=0.29). The mean change in best corrected visual acuity was 0.41 logMAR for POAG and 0.38 logMAR for CPACG at the last follow-up (P=0.22). The postoperative intraocular pressure (IOP) of the POAG group was significantly lower than the CPACG group at 1, 3, 12, and 18mo after surgery (P=0.02, 0.00, 0.04, 0.01) with similar glaucoma medications after surgery (P>0.16). At 3y after surgery, the cumulative complete and qualified success rates were 63.3% (POAG) and 53.3% (CPACG), 83.3% (POAG) and 73.3% (CPACG) (P=0.41, 0.49), respectively. The POAG group had more hypotony than the CPACG group (P=0.04).CONCLUSIONThe long-term outcomes show the Ex-PRESS implantation combined with phacoemulcification can effectively lower the IOP in both the POAG and CPACG groups. The POAG group seems to have lower postoperative IOP and a higher risk of hypotony.
To compare the long-term outcomes of the Ex-PRESS miniature glaucoma device implanted under a scleral flap in combination of phacoemulsification with intraocular lens implantation in primary open angle glaucoma (POAG) and chronic primary angle-closure glaucoma (CPACG). Retrospective, comparative study. A total of 60 eyes (60 patients) receiving the Ex-PRESS miniature glaucoma device implantation combined with phacoemulsification were reviewed. Thirty eyes (30 patients) had the combined procedures for POAG, and the other 30 eyes (30 patients) for CPACG. The follow-up was 39.37±7.09mo (range 3 to 49mo) in patients with POAG and 37.10±9.26mo (range 9 to 49mo) in patients with CPACG ( =0.29). The mean change in best corrected visual acuity was 0.41 logMAR for POAG and 0.38 logMAR for CPACG at the last follow-up ( =0.22). The postoperative intraocular pressure (IOP) of the POAG group was significantly lower than the CPACG group at 1, 3, 12, and 18mo after surgery ( =0.02, 0.00, 0.04, 0.01) with similar glaucoma medications after surgery ( >0.16). At 3y after surgery, the cumulative complete and qualified success rates were 63.3% (POAG) and 53.3% (CPACG), 83.3% (POAG) and 73.3% (CPACG) ( =0.41, 0.49), respectively. The POAG group had more hypotony than the CPACG group ( =0.04). The long-term outcomes show the Ex-PRESS implantation combined with phacoemulcification can effectively lower the IOP in both the POAG and CPACG groups. The POAG group seems to have lower postoperative IOP and a higher risk of hypotony.
AIM: To compare the long-term outcomes of the Ex-PRESS miniature glaucoma device implanted under a scleral flap in combination of phacoemulsification with intraocular lens implantation in primary open angle glaucoma (POAG) and chronic primary angle-closure glaucoma (CPACG).METHODS: Retrospective, comparative study. A total of 60 eyes (60 patients) receiving the Ex-PRESS miniature glaucoma device implantation combined with phacoemulsification were reviewed. Thirty eyes (30 patients) had the combined procedures for POAG, and the other 30 eyes (30 patients) for CPACG. RESULTS: The follow-up was 39.37±7.09mo (range 3 to 49mo) in patients with POAG and 37.10±9.26mo (range 9 to 49mo) in patients with CPACG (P=0.29). The mean change in best corrected visual acuity was 0.41 logMAR for POAG and 0.38 logMAR for CPACG at the last follow-up (P=0.22). The postoperative intraocular pressure (IOP) of the POAG group was significantly lower than the CPACG group at 1, 3, 12, and 18mo after surgery (P=0.02, 0.00, 0.04, 0.01) with similar glaucoma medications after surgery (P〉0.16). At 3y after surgery, the cumulative complete and qualified success rates were 63.3% (POAG) and 53.3% (CPACG), 83.3% (POAG) and 73.3% (CPACG) (P=0.41, 0.49), respectively. The POAG group had more hypotony than the CPACG group (P=0.04).CONCLUSION: The long-term outcomes show the Ex-PRESS implantation combined with phacoemulcification can effectively lower the IOP in both the POAG and CPACG groups. The POAG group seems to have lower postoperative IOP and a higher risk of hypotony.
Author Jie Lan Da-Peng Sun Jie Wu Ya-Ni Wang Li-Xin Xie
AuthorAffiliation Qingdao University Medical College, Qingdao 266071, ShandongProvince, China Qingdao Eye Hospital, Shandong Eye Institute, ShandongAcademy of Medical Sciences, Qingdao 266071, ShandongProvince, China
AuthorAffiliation_xml – name: 1 Qingdao University Medical College, Qingdao 266071, Shandong Province, China
– name: 2 Qingdao Eye Hospital, Shandong Eye Institute, Shandong Academy of Medical Sciences, Qingdao 266071, Shandong Province, China
Author_xml – sequence: 1
  givenname: Jie
  surname: Lan
  fullname: Lan, Jie
  organization: Qingdao University Medical College, Qingdao 266071, Shandong Province, China; Qingdao Eye Hospital, Shandong Eye Institute, Shandong Academy of Medical Sciences, Qingdao 266071, Shandong Province, China
– sequence: 2
  givenname: Da-Peng
  surname: Sun
  fullname: Sun, Da-Peng
  organization: Qingdao Eye Hospital, Shandong Eye Institute, Shandong Academy of Medical Sciences, Qingdao 266071, Shandong Province, China
– sequence: 3
  givenname: Jie
  surname: Wu
  fullname: Wu, Jie
  organization: Qingdao Eye Hospital, Shandong Eye Institute, Shandong Academy of Medical Sciences, Qingdao 266071, Shandong Province, China
– sequence: 4
  givenname: Ya-Ni
  surname: Wang
  fullname: Wang, Ya-Ni
  organization: Qingdao Eye Hospital, Shandong Eye Institute, Shandong Academy of Medical Sciences, Qingdao 266071, Shandong Province, China
– sequence: 5
  givenname: Li-Xin
  surname: Xie
  fullname: Xie, Li-Xin
  organization: Qingdao Eye Hospital, Shandong Eye Institute, Shandong Academy of Medical Sciences, Qingdao 266071, Shandong Province, China
BackLink https://www.ncbi.nlm.nih.gov/pubmed/28149776$$D View this record in MEDLINE/PubMed
BookMark eNpVUU1Lw0AQXUSxWj17k-DJS-p-7_YilFCrIFisnpdNsmlXkt02m1T996YfFp3LDLw37zHzzsGx884AcIXgAElM4Z398AMMkRhANIDyCJxhjEVM5VAeb2cckyEb9sBlCB-wK84ggvQU9LBEdCgEPwPJ-Cuevo5ns8hWy1K7RjfWu-jTNotoudCZN1VbBlvYbAdYF01fRpNoberQhiiZjpLJBTgpdBnM5b73wfvD-C15jJ9fJk_J6DnOiKBNTLEWSEIj8hxyU0jGiwzRQkuU5gQKLDNJKJcE6pRoxLimqSgMToXORZoyTvrgfqe7bNPK5JlxTa1Ltaxtpetv5bVV_xFnF2ru14phzAiVncDtXqD2q9aERlU2ZKbs7ja-DQpJzhgRBNGOev3X62Dy-7mOcLcjZLUPoTbFgYKg2sajunjUJh4FkYIb95v9xsK7-cq6-WGFi86SCc7JD79yjW0
ContentType Journal Article
Copyright International Journal of Ophthalmology Press 2017
Copyright_xml – notice: International Journal of Ophthalmology Press 2017
DBID 2RA
92L
CQIGP
W91
~WA
AAYXX
CITATION
NPM
7X8
5PM
DOI 10.18240/ijo.2017.01.08
DatabaseName 维普_期刊
中文科技期刊数据库-CALIS站点
维普中文期刊数据库
中文科技期刊数据库-医药卫生
中文科技期刊数据库- 镜像站点
CrossRef
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
PubMed

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
DocumentTitleAlternate Ex-PRESS implantation with phacoemulsification in POAG versus CPACG
EISSN 2227-4898
EndPage 55
ExternalDocumentID PMC5225348
28149776
10_18240_ijo_2017_01_08
671435766
Genre Journal Article
GroupedDBID -SE
-S~
2RA
53G
5VR
5VS
92L
ABKZE
AENEX
AFUIB
ALMA_UNASSIGNED_HOLDINGS
CAJEE
CAJUS
CCEZO
CHBEP
CIEJG
CQIGP
DIK
FA0
GROUPED_DOAJ
HYE
IPNFZ
Q--
Q-4
RIG
RNS
RPM
U1G
U5O
W91
~WA
AAYXX
CITATION
NPM
7X8
5PM
ID FETCH-LOGICAL-c374t-42a7180e7dd06ef856fc14fa81bd30728c8346830ab3a156a4b7fe2b7ad7bb563
ISSN 2222-3959
IngestDate Thu Aug 21 14:09:17 EDT 2025
Thu Jul 10 22:41:35 EDT 2025
Thu Jan 02 22:29:58 EST 2025
Tue Jul 01 04:14:56 EDT 2025
Wed Feb 14 10:05:17 EST 2024
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Ex-PRESS miniature glaucoma device
cataract surgery
glaucoma
phacoemulsification
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c374t-42a7180e7dd06ef856fc14fa81bd30728c8346830ab3a156a4b7fe2b7ad7bb563
Notes glaucoma; Ex-PRESS miniature glaucomadevice; cataract surgery; phacoemulsification
AIM: To compare the long-term outcomes of the Ex-PRESS miniature glaucoma device implanted under a scleral flap in combination of phacoemulsification with intraocular lens implantation in primary open angle glaucoma (POAG) and chronic primary angle-closure glaucoma (CPACG).METHODS: Retrospective, comparative study. A total of 60 eyes (60 patients) receiving the Ex-PRESS miniature glaucoma device implantation combined with phacoemulsification were reviewed. Thirty eyes (30 patients) had the combined procedures for POAG, and the other 30 eyes (30 patients) for CPACG. RESULTS: The follow-up was 39.37±7.09mo (range 3 to 49mo) in patients with POAG and 37.10±9.26mo (range 9 to 49mo) in patients with CPACG (P=0.29). The mean change in best corrected visual acuity was 0.41 logMAR for POAG and 0.38 logMAR for CPACG at the last follow-up (P=0.22). The postoperative intraocular pressure (IOP) of the POAG group was significantly lower than the CPACG group at 1, 3, 12, and 18mo after surgery (P=0.02, 0.00, 0.04, 0.01) with similar glaucoma medications after surgery (P〉0.16). At 3y after surgery, the cumulative complete and qualified success rates were 63.3% (POAG) and 53.3% (CPACG), 83.3% (POAG) and 73.3% (CPACG) (P=0.41, 0.49), respectively. The POAG group had more hypotony than the CPACG group (P=0.04).CONCLUSION: The long-term outcomes show the Ex-PRESS implantation combined with phacoemulcification can effectively lower the IOP in both the POAG and CPACG groups. The POAG group seems to have lower postoperative IOP and a higher risk of hypotony.
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink http://www.ijo.cn/create_pdf.aspx?file_no=20170108&flag=1&journal_id=gjyken
PMID 28149776
PQID 1865537314
PQPubID 23479
PageCount 5
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_5225348
proquest_miscellaneous_1865537314
pubmed_primary_28149776
crossref_primary_10_18240_ijo_2017_01_08
chongqing_primary_671435766
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2017-01-18
PublicationDateYYYYMMDD 2017-01-18
PublicationDate_xml – month: 01
  year: 2017
  text: 2017-01-18
  day: 18
PublicationDecade 2010
PublicationPlace China
PublicationPlace_xml – name: China
PublicationTitle International journal of ophthalmology
PublicationTitleAlternate International Journal of Ophthalmology
PublicationYear 2017
Publisher International Journal of Ophthalmology Press
Publisher_xml – name: International Journal of Ophthalmology Press
References 17061230 - Eur J Ophthalmol. 2006 Sep-Oct;16(5):753-5
24232313 - Eye (Lond). 2014 Jan;28(1):1-8
24465860 - PLoS One. 2014 Jan 23;9(1):e86045
15741808 - J Glaucoma. 2005 Apr;14(2):98-102
16488940 - Br J Ophthalmol. 2006 Mar;90(3):262-7
24767229 - Can J Ophthalmol. 2014 Apr;49(2):200-4
23617934 - Acta Ophthalmol. 2013 Sep;91(6):e500-1
19668548 - Clin Ophthalmol. 2009;3:81-7
22196977 - Ophthalmology. 2012 Apr;119(4):694-702
19223790 - J Glaucoma. 2009 Aug;18(6):488-91
23741296 - PLoS One. 2013 May 31;8(5):e63591
16462873 - Can J Ophthalmol. 2006 Feb;41(1):51-9
23990272 - Jpn J Ophthalmol. 2013 Nov;57(6):520-8
22274666 - J Glaucoma. 2013 Mar;22(3):209-14
20051881 - J Glaucoma. 2011 Jan;20(1):57-62
16086969 - Am J Ophthalmol. 2005 Aug;140(2):340-1
23912181 - Jpn J Ophthalmol. 2013 Nov;57(6):514-9
17964403 - J Cataract Refract Surg. 2007 Nov;33(11):1946-52
22895522 - J Glaucoma. 2014 Feb;23(2):88-94
24810572 - Eye (Lond). 2014 Aug;28(8):1034
16647135 - Ophthalmology. 2006 Jun;113(6):930-6
17224744 - J Glaucoma. 2007 Jan;16(1):14-9
20623471 - Eur J Ophthalmol. 2011 Jan-Feb;21(1):12-9
References_xml – reference: 19668548 - Clin Ophthalmol. 2009;3:81-7
– reference: 24810572 - Eye (Lond). 2014 Aug;28(8):1034
– reference: 20623471 - Eur J Ophthalmol. 2011 Jan-Feb;21(1):12-9
– reference: 20051881 - J Glaucoma. 2011 Jan;20(1):57-62
– reference: 15741808 - J Glaucoma. 2005 Apr;14(2):98-102
– reference: 24767229 - Can J Ophthalmol. 2014 Apr;49(2):200-4
– reference: 23617934 - Acta Ophthalmol. 2013 Sep;91(6):e500-1
– reference: 22895522 - J Glaucoma. 2014 Feb;23(2):88-94
– reference: 23990272 - Jpn J Ophthalmol. 2013 Nov;57(6):520-8
– reference: 19223790 - J Glaucoma. 2009 Aug;18(6):488-91
– reference: 17964403 - J Cataract Refract Surg. 2007 Nov;33(11):1946-52
– reference: 17061230 - Eur J Ophthalmol. 2006 Sep-Oct;16(5):753-5
– reference: 23912181 - Jpn J Ophthalmol. 2013 Nov;57(6):514-9
– reference: 24465860 - PLoS One. 2014 Jan 23;9(1):e86045
– reference: 17224744 - J Glaucoma. 2007 Jan;16(1):14-9
– reference: 23741296 - PLoS One. 2013 May 31;8(5):e63591
– reference: 22196977 - Ophthalmology. 2012 Apr;119(4):694-702
– reference: 16086969 - Am J Ophthalmol. 2005 Aug;140(2):340-1
– reference: 16462873 - Can J Ophthalmol. 2006 Feb;41(1):51-9
– reference: 16647135 - Ophthalmology. 2006 Jun;113(6):930-6
– reference: 16488940 - Br J Ophthalmol. 2006 Mar;90(3):262-7
– reference: 22274666 - J Glaucoma. 2013 Mar;22(3):209-14
– reference: 24232313 - Eye (Lond). 2014 Jan;28(1):1-8
SSID ssj0000650104
Score 2.0628545
Snippet AIM: To compare the long-term outcomes of the Ex-PRESS miniature glaucoma device implanted under a scleral flap in combination of phacoemulsification with...
To compare the long-term outcomes of the Ex-PRESS miniature glaucoma device implanted under a scleral flap in combination of phacoemulsification with...
AIMTo compare the long-term outcomes of the Ex-PRESS miniature glaucoma device implanted under a scleral flap in combination of phacoemulsification with...
SourceID pubmedcentral
proquest
pubmed
crossref
chongqing
SourceType Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage 51
SubjectTerms Clinical Research
Title Ex-PRESS implantation with phacoemulsification in POAG versus CPACG
URI http://lib.cqvip.com/qk/60944X/201701/671435766.html
https://www.ncbi.nlm.nih.gov/pubmed/28149776
https://www.proquest.com/docview/1865537314
https://pubmed.ncbi.nlm.nih.gov/PMC5225348
Volume 10
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLbKkBAviDvdAAWJB6TJkIsdu49VNTZNdKvEJsZTZCcOLWrTjjYS4q_wZzkndkLS7gH2ElWOm7j-Pp9bj48JeQs62EShzKgEulAm05RKHhsacKFAGw1UwHGD8_gsPrlkp1f8qtf73cpaKjf6ffrrxn0lt0EV2gBX3CX7H8g2D4UG-Az4whUQhus_YXz0k1YziHsd56pwiYNVaHU1BVFnFuV8jblAqk5pnJwPjw8xE6NcH44mw9Fx2zjtRgdbNSWWq-lmquaLTgj-kw2dns4aanwurQhTdGKcQkRxX251--JC1F8VPZu1ow4BpqdSJygrT3QnXOkGdN4eUCeNBCQa2CIhjQauBLip2wRwxB5F3Yhkf4d6Vr664rRWU9v6vjs6QIKRAsjNvuPezkBUVVlluyeAuFpUlAglOIhCbNXirrT7ZDwC05RHTN4hd0MBhlnLX7dqnqMvi4cX1j_LlY7CAXzovh5rTrt3YRGP6bL4dg2mSdcY2vFwthN1W5bPxUPywE27N7T8e0R6pnhM7o1dUsYTMqpp6LVp6CENvRto6M0KD2noWRp6FQ2fksuPRxejE-rO5qBpJNiGslCBVeMbkWV-bHJY33kasFyBF5SB2ghlKiMWy8hXOoL1HiumRW5CLVQmtOZx9IzsFcvCvCBexkMm_VBnnBk20FynvlKZTkMF_XTO--SgmbBkZWuwJLFAQx9g6ZN39RQ2N9GxRRASACFBEBI_SHzZJ2_qKU5AiOI_Y6owy3INvWPOIxEFrE-e2ylvHlbj1ieiA0bTAQu0d-8Us2lVqN0RaP_W3zwg9_8uvpdkb_OjNK_ACN7o1xUZ_wBIvrIW
linkProvider Directory of Open Access Journals
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Ex-PRESS+implantation+with+phacoemulsification+in+POAG+versus+CPACG&rft.jtitle=International+journal+of+ophthalmology&rft.au=Lan%2C+Jie&rft.au=Sun%2C+Da-Peng&rft.au=Wu%2C+Jie&rft.au=Wang%2C+Ya-Ni&rft.date=2017-01-18&rft.pub=International+Journal+of+Ophthalmology+Press&rft.issn=2222-3959&rft.eissn=2227-4898&rft.volume=10&rft.issue=1&rft.spage=51&rft.epage=55&rft_id=info:doi/10.18240%2Fijo.2017.01.08&rft_id=info%3Apmid%2F28149776&rft.externalDocID=PMC5225348
thumbnail_s http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fimage.cqvip.com%2Fvip1000%2Fqk%2F60944X%2F60944X.jpg